|Day's range||55.05 - 55.05|
Yahoo Finance’s Anjalee Khemlani joins the Live show to discuss Moderna CEO Stephane Bancel’s testimony before the U.S. Senate health committee.
Moderna's (NASDAQ: MRNA) success in the coronavirus vaccine race has equaled success for early investors. Let's take a look at how much you would have today if you'd invested $5,000 in Moderna back in 2020. Moderna became one of the first to bring a coronavirus vaccine candidate into clinical trials.
Moderna CEO Stéphane Bancel is set to face Sen. Bernie Sanders to defend the company's fast growth and planned price hike of its COVID-19 vaccine.